Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

<p>supplemental tables 5-7</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Junko Tsuji (15051410) (author)
Diğer Yazarlar:	Tianyu Li (15050574) (author), Albert Grinshpun (15051413) (author), Tim Coorens (15051416) (author), Douglas Russo (15051419) (author), Leilani Anderson (15051422) (author), Rebecca Rees (15051425) (author), Agostina Nardone (14958879) (author), Candace Patterson (15051428) (author), Niall J. Lennon (15051431) (author), Carrie Cibulskis (15051434) (author), Ignaty Leshchiner (15051437) (author), Nabihah Tayob (15029789) (author), Sara M. Tolaney (15051440) (author), Nadine Tung (15051443) (author), Donald P. McDonnell (15051446) (author), Ian E. Krop (15029231) (author), Eric P. Winer (14958942) (author), Chip Stewart (15021003) (author), Gad Getz (14945542) (author), Rinath Jeselsohn (14948026) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Breast Cancer Drug Targets Genome Biology Tumor Evolution Tumor Heterogeneity
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
Yazar:: Juliana Navarro-Yepes (17079059)
Baskı/Yayın Bilgisi: (2025)

2- Exome sequencing of sample tumor tissue 1- Exome sequencing of sample matched normal tissue
Yazar:: Hossein Khanahmad (21998459)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables from Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells
Yazar:: Francesco Maura (15022226)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
Yazar:: Francisco Hermida-Prado (14958909)
Baskı/Yayın Bilgisi: (2025)

Suppl Data 2 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
Yazar:: Marija Pizurica (17060224)
Baskı/Yayın Bilgisi: (2025)

Suppl. Data 1 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
Yazar:: Marija Pizurica (17060224)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie 1 from The Macrophage-Associated LncRNA <i>MALR</i> Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer
Yazar:: Jia Liu (15386858)
Baskı/Yayın Bilgisi: (2025)

Classification of Udai21 and the World Rice Core Collection based on whole genome sequencing data.
Yazar:: Hiroki Ikeda (510280)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
Yazar:: Andrew A. Davis (15030032)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Yazar:: Lavanya Sivapalan (15314248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1_Primer and shRNA sequences_PCR cycles_Mycoplasma testing from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_Whole genome sequencing as a reliable alternative for Salmonella serotyping: a comparative study with the gold-standard method.pdf
Yazar:: Irene Mileto (20877575)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Yazar:: Kala Visvanathan (14952973)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Yazar:: Kala Visvanathan (14952973)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Yazar:: Kala Visvanathan (14952973)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Yazar:: Kala Visvanathan (14952973)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Yazar:: Kala Visvanathan (14952973)
Baskı/Yayın Bilgisi: (2025)

Table S1 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
Yazar:: Hanyun Zhang (15386757)
Baskı/Yayın Bilgisi: (2025)

Table S2 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
Yazar:: Hanyun Zhang (15386757)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 10_Pro metastatic pathways identified by classification analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2_Predictive power of genes and signatures_Patient cohorts GEO accession number from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 3_Clonal distribution analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 4_Marker genes all and some per cluster_GO and curated pathways per cluster from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 5_Marker genes all and some per cluster no cell cycle_GO and curated pathways per cluster no cell cycle from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 8_Genes identified by classification analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
Yazar:: Niccolò Roda (16437288)
Baskı/Yayın Bilgisi: (2025)

Table S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
Yazar:: Bahar Rastegar (16031079)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_a1f5koq50i807hcedgphdt4qa7